Group 1 - The core viewpoint of the news is that Kangtong Medical has experienced a decline in both revenue and net profit for the first quarter of 2025, alongside notable trading activity in its stock [1][2]. - As of August 4, 2023, Kangtong Medical's stock price decreased by 0.48%, with a trading volume of 59.78 million yuan. The net financing buy was negative at -3.53 million yuan, indicating more repayments than new purchases [1]. - The financing balance of Kangtong Medical reached 39.83 million yuan, accounting for 2.52% of its market capitalization, which is above the 50th percentile level over the past year, suggesting a relatively high level of financing [1]. Group 2 - Kangtong Medical's main business revenue composition includes 65.42% from clean medical equipment and systems, 29.43% from medical gas equipment and systems, 3.01% from medical device sales, 1.85% from operation and maintenance services, and 0.30% from other sources [1]. - As of July 31, 2023, the number of shareholders for Kangtong Medical was 8,816, an increase of 1.15% from the previous period, while the average circulating shares per person decreased by 1.13% to 7,222 shares [2]. - For the first quarter of 2025, Kangtong Medical reported a revenue of 24.29 million yuan, a significant year-on-year decrease of 68.09%, and a net profit attributable to the parent company of 1.58 million yuan, down 85.25% year-on-year [2]. Group 3 - Since its A-share listing, Kangtong Medical has distributed a total of 48.99 million yuan in dividends [3].

港通医疗8月4日股价报22.64元，较前一交易日下跌0.48%。当日成交量为26485手，成交金额达0.6亿 元。该股开盘价为22.75元，盘中最高触及22.92元，最低下探至22.25元。 公司最新公告显示，截至7月31日，港通医疗已累计回购286万股，占总股本的2.86%，回购总金额5305 万元，回购价格区间为16.57元至19.68元。此外，公司披露截至7月31日股东总户数为8816户，较7月18 日增加100户。 港通医疗主营业务涵盖医用洁净装备及系统、医用气体装备及系统等医疗设备领域。公司2024年年报显 示，医用洁净装备及系统业务占比达65.42%，医用气体装备及系统业务占比29.43%。 风险提示：投资有风险，入市需谨慎。 来源：金融界 8月4日主力资金净流出249.77万元，占流通市值的0.17%。近五个交易日累计净流出939.02万元，占流 通市值的0.65%。 ...

证券日报网讯 8月4日晚间，港通医疗发布公告称，截至2025年7月31日，公司通过股票回购专用证券账 户以集中竞价交易方式回购股份，累计回购股份数量为2，858，786股，占公司总股本的2.86%。 （文章来源：证券日报） ...

证券日报网讯港通医疗（301515）8月4日在互动平台回答投资者提问时表示，公司截至2025年7月31日 股东总户数为8816户。 ...

格隆汇8月4日丨港通医疗(301515.SZ)公布，截至2025年7月31日，公司通过股票回购专用证券账户以集 中竞价交易方式回购股份，累计回购股份数量为2,858,786股，占公司总股本的2.86%，其中最高成交价 为19.68元/股，最低成交价为16.57元/股，成交总金额为5304.62万元(不含交易费用)。 ...

2024年1至12月份，港通医疗的营业收入构成为：医用洁净装备及系统占比65.42%，医用气体装备及系 统占比29.43%，医疗设备及其他产品销售占比3.01%，运维服务占比1.85%，其他业务占比0.3%。 （文章来源：每日经济新闻） 港通医疗（SZ 301515，收盘价：22.64元）8月4日晚间发布公告称，截至2025年7月31日，公司通过股 票回购专用证券账户以集中竞价交易方式回购股份，累计回购股份数量约为286万股，占公司总股本的 2.86%，其中最高成交价为19.68元/股，最低成交价为16.57元/股，成交总金额约为5305万元。 ...

格隆汇8月4日丨港通医疗(301515.SZ)公布，截至2025年7月31日，公司通过股票回购专用证券账户以集 中竞价交易方式回购股份，累计回购股份数量为2,858,786股，占公司总股本的2.86%，其中最高成交价 为19.68元/股，最低成交价为16.57元/股，成交总金额为5304.62万元(不含交易费用)。 ...

证券代码：301515 证券简称：港通医疗 公告编号：2025-046 四川港通医疗设备集团股份有限公司 关于2024年第二次回购公司股份进展的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 四川港通医疗设备集团股份有限公司（以下简称"公司"）于 2024 年 11 月 4 日召开第四届董事会第十七次会议和第四届监事会第十七次会议，审议通过 《关于 2024 年第二次回购公司股份方案的议案》，公司拟使用不低于人民币 5,000 万元（含）且不超过人民币 10,000 万元（含）的自有资金和专项回购贷款 资金以集中竞价交易的方式回购公司已发行的人民币普通股（A 股）股票，回购 价格不超过人民币 28.49 元/股（含），回购的股份将用于实施员工持股计划或股 权激励。本次回购股份的实施期限为自公司董事会审议通过本次回购股份方案之 日起不超过 12 个月。具体回购股份的数量以回购期满或回购完毕时公司实际回 购的股份数量为准。 公司于 2024 年 11 月 8 日召开 2024 年第一次临时股东会，审议通过《关于 公司 2024 年前三季度利润分配预案的议案》 ...

Summary of Key Points Core Viewpoint - 港通医疗 has shown a slight increase in shareholder numbers, with a modest rise in average shareholding value despite a small decrease in average shareholding quantity [1] Group 1: Shareholder Statistics - As of July 31, 2025, 港通医疗 had 8,816 shareholders, an increase of 100 from the previous period, representing a growth rate of 1.15% [1] - The average number of shares held per shareholder decreased from 11,500 shares to 11,300 shares [1] - The average market value of shares held per shareholder increased from 245,200 yuan to 249,500 yuan [1] Group 2: Stock Performance - During the observed period, 港通医疗's stock price increased by 4.28% [1] - As of the latest report, 港通医疗's stock price was 22.68 yuan, reflecting a decrease of 0.31% [1] - The company's market capitalization stands at 2.268 billion yuan [1] Group 3: Historical Data Comparison - The changes in shareholder numbers and average holdings over the last five reporting dates are as follows: - July 31, 2025: 8,816 shareholders, 11.3 million shares, 249.5 thousand yuan - July 18, 2025: 8,716 shareholders, 11.5 million shares, 245.2 thousand yuan - July 10, 2025: 9,194 shareholders, 9.1 million shares, 231.7 thousand yuan - June 30, 2025: 8,154 shareholders, 11.2 million shares, 249.3 thousand yuan - June 20, 2025: 7,958 shareholders, 12.6 million shares, 233.7 thousand yuan [1]

Group 1 - The core viewpoint of the news highlights the trading performance and financial metrics of Kangtong Medical, indicating a mixed outlook with a notable decrease in revenue and profit [1][2]. - On August 1, Kangtong Medical's stock rose by 3.41%, with a trading volume of 83.28 million yuan. The financing buy-in amounted to 7.22 million yuan, while the financing repayment was 8.73 million yuan, resulting in a net financing outflow of 1.50 million yuan [1]. - As of August 1, the total balance of margin trading for Kangtong Medical was 43.36 million yuan, accounting for 2.73% of its market capitalization, which is above the 60th percentile of the past year [1]. Group 2 - The company reported a significant decline in revenue for the first quarter of 2025, with operating income of 24.29 million yuan, a year-on-year decrease of 68.09%, and a net profit attributable to shareholders of 1.58 million yuan, down 85.25% year-on-year [2]. - As of July 18, the number of shareholders for Kangtong Medical was 8,716, a decrease of 5.20% from the previous period, while the average circulating shares per person increased by 5.48% to 7,305 shares [2]. - Since its A-share listing, Kangtong Medical has distributed a total of 48.99 million yuan in dividends [3].